Literature DB >> 17888601

Malignant fibrous histiocytoma of the bucca: a case report.

Hiromi Nagano1, Kouji Deguchi, Yuichi Kurono.   

Abstract

Malignant fibrous histiocytoma (MFH) is the most common soft-tissue sarcoma, but is relatively uncommon in head and neck area. Histologically, it is difficult to distinguish this tumor from other sarcomas and carcinomas. Surgery is the most reliable treatment for MFH, but the 5-year survival rate for cases of this tumor in the head and neck is low in comparison with MFH of the extremities and trunk. In the case reported here, the patient was a 61-year-old man who presented with swelling and pain of the left bucca. A CT scan demonstrated a 2.5 cm x 5.0 cm inhomogeneous lesion. In MRI, the tumor displayed an inhomogeneous isointense signal on T1-weighted images and a high-intensity signal on T2-weighted images. Fine-needle aspiration (FNA) was performed twice but we were unable to reach a definitive diagnosis histologically. MFH was subsequently diagnosed by open biopsy, and external radiotherapy with 38 Gy of radiation was performed. However, the tumor enlarged after this therapy, and therefore CyberKnife therapy was performed twice, after which the tumor gradually reduced in size. The patient is alive after a follow-up period of 22 months, and therefore we suggest that CyberKnife treatment may be useful for head and neck MFH.

Entities:  

Mesh:

Year:  2007        PMID: 17888601     DOI: 10.1016/j.anl.2007.04.016

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Computed tomography and magnetic resonance imaging findings of malignant fibrous histiocytoma of the head and neck.

Authors:  Jing Li; Zhi-Jun Geng; Xiao-Fei Lv; Xin-Ke Zhang; Chuan-Miao Xie
Journal:  Mol Clin Oncol       Date:  2016-03-09

2.  CyberKnife radiotherapy for malignant fibrous histiocytoma of the chest wall: A case report and review of the literature.

Authors:  Zhen Wang; Xin-Hu Wu; Bing Li; Qing-Tao Kong; Ze-Tian Shen; Jing Li; Zhi-Bing Liu; Xi-Xu Zhu
Journal:  Oncol Lett       Date:  2014-03-24       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.